HEIDELBERG, Germany, July 8 -- EMBO Molecular Medicine, a peer-reviewed journal that says it features clinical research and basic biology, published research articles on the following topics in its July 7, 2022 edition:

Articles:

* Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia

* The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib